Table 1.
Baseline clinical characteristics
| All subjects (n = 3171) | |
|---|---|
| Age (years) | 65.0 ± 11.3 |
| Sex (male) | 1889 (59.6%) |
| Body mass index (kg/m2) | 25.1 ± 4.2 |
| Diabetes mellitus duration (years) | 10.5 ± 7.6 |
| Hypertension | 1978 (65.3%) |
| Family history of coronary heart disease | 266 (14.7%) |
| Smoking history | |
| Current | 653 (23.3%) |
| Former | 575 (20.5%) |
| Never | 1573 (56.1%) |
| Comorbidity | |
| Coronary artery disease | 492 (15.6%) |
| Cerebrovascular disease | 303 (9.6%) |
| Peripheral artery disease | 9 (0.3%) |
| Diabetic microvascular complications | |
| Retinopathy | 456 (14.4%) |
| Neuropathy | 428 (13.6%) |
| Nephropathy | 564 (17.9%) |
| Medications | |
| Sulfonylurea | 1583 (49.9%) |
| Thiazolidinedione | 695 (21.9%) |
| Glinide | 64 (2.0%) |
| Alpha-glucosidase inhibitor | 428 (13.5%) |
| Metformin | 1255 (39.6%) |
| Insulin | 215 (6.8%) |
| Aspirin | 556 (22.2%) |
| Statin | 1397 (55.7%) |
Data are expressed as mean ± SD or percentage